Prevalence of hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-Eastern Nigeria

Pan African Medical Journal

Volumn 14, Issue , 2013, Pages

  Nwolisa, Emeka ^a   Mbanefo, Francis ^a   Ezeogu, Joseph ^a   Amadi, Paul ^a  

^a FEDERAL MEDICAL CENTER   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; AGE DISTRIBUTION; ANTIGEN DETECTION; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILD CARE; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NIGERIA; OUTCOME ASSESSMENT; PREVALENCE; SEX DIFFERENCE;

EID: 84876491136     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.14.89.1711     Document Type: Article

References (23)

1. UNAIDS. UNAIDS Report. 2006. UNAIDS. Geneva.
2. Federal Ministry of Health. National Guildlines for Paediatric HIV and AIDS treatment and care. 2007. Federal Ministry of Health. Abuja.
3. UNAIDS. Report on the global AIDS epidemic. UNAIDS. 2008. Geneva.
4. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and Clinical associations of genotypes. Hepatol Res. 2007; 37: S9-S19.
5. Ejele OA, Ojule AC. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med. 2004;13: 336-38.
6. Adoga MP, Gyar SD, Pechulano S, Bashayi OD et al. Hepatitis B virus infections in apparently healthy urban Nigerians: Data from pre-vaccination tests. J Infect Dev Ctries. 2010;30:397-400.
7. Aganga-Williams OM, Akanmu AS, Akinsete I. Prevalence of hepatitis B surface antigen among women of child-bearing age in Lagos State. Afr J of Rep Hlth.1999; 3: 45-50.
8. Alikor EA, Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Niger J Med. 2007;16:250-1.
9. Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J. 2005;24:755-60.
10. Mathews G, Bhagani S. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. J HIV Ther. 2003;8:77-84.
11. Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health. 2007;22:338.
12. Rana C, Gareth R, Dimitra B, Alexandra M, Jedediah R et al. Viral co-infection among Children Infected with HIV Type 1. Clin Infect Dis. 2003;36:922-24.
13. Zhou S, Zhao Y, He Y, Li H, Bulterys M, Sun X et al. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009. J Acquir Immune Defic Syndr. 2010;54:191-6.
14. Ashir GM, Rabasa AI, Gofama MM, Bukbuk D, Abubakar H, Farouk GA. Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. Niger J Med. 2009;18:260-2.
15. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200:39-47.
16. Wolters LM, Niesters HG, Hansen BE et al. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. J Clin Virol. 2002;24:173-81.
17. Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P et al. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. Clin Infect Dis. 2008; 46:361-6.
18. Guan R. Treatment of chronic hepatitis B in HIV co-infected patients. Med J Malaysia. 2005; 60 Suppl B:52-6.
19. Sulkowski.MS. Viral hepatitis and HIV coinfection. J Hepatol. 2008;48:353-67.
20. Levy V, Grant RM. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis. 2006;43:904-10.
21. Iser DM, Sasadeusz JJ. Current treatment of HIV/hepatitis B virus coinfection. J Gastroenterol Hepatol. 2008;23:699-706.
22. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol. 2008;29:136-47.
23. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94-103.